Health services research in psoriasis - The German approach

Dermatology

Volumn 218, Issue 4, 2009, Pages 293-301

  Augustin, M ^a   Reich, K ^b   Reusch, M ^c   Luger, T ^d   Franzke, N ^a   Schafer I ^a   Rustenbach, S J ^a   Radtke, M A ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Dermatologikum   (Germany)

^c Dermatologic Practice   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Health care guidelines; Health care provision; Psoriasis

Indexed keywords

DISEASE SEVERITY; EDITORIAL; GERMANY; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; RESOURCE ALLOCATION;

GERMANY; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HUMANS; PSORIASIS; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE;

EID: 67651123106     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207853     Document Type: Editorial

References (41)

1. Nijsten Z, Wakkee M: Psocare: Italy shows the way in postmarketing studies. Dermatology 2008; 217: 362-364.
2. Schmitt J, Meurer M, Klon M, Frick KD: Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study. Br J Dermatol 2008; 158: 351-359.
3. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC: The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996; 276: 1172-1177. (Pubitemid 26329746)
4. Schaefer I, Zimmer L, Rustenbach SJ, Augustin M: Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169-172.
5. Radtke MA, Augustin M: Economic considerations in psoriasis management. Clin Dermatol 2008; 26: 424-431.
6. Greaves MW, Weinstein GD: Treatment of psoriasis. N Engl J Med 1995; 332: 581-588.
7. Sohn S, Schöffski O, Prinz K, Schubert E, Waldorf K, Augustin M: Cost of moderate to severe plaque psoriasis in Germany: a multicenter cost-of-illness study. Dermatology 2006; 212: 137-144. (Pubitemid 43260729)
8. Berger K, Ehlken B, Kugland B, Augustin M: Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges 2005; 3: 511-518. (Pubitemid 40942633)
9. Feldman SR, Fleischer AB, Reboussin DM, Rapp SR, Bradham DD, Exum ML, Clark AR: The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997; 37: 564-569.
10. Radtke M, Augustin M: Kosten und Wirtschaftlichkeit der Psoriasistherapie. Gesellschaftspolitische Kommentare 2008; 1: 26-29.
11. Heinen-Kammerer T, Daniel D, Stratmann L, Rychlik R, Boehncke WH: Cost-effectiveness of psoriasis therapy with etanercept in Germany. J Dtsch Dermatol Ges 2007; 5: 762-768. (Pubitemid 47382958)
12. Finlay AY, Coles EC: The effects of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-244.
13. Fried RG, Friedman S, Paradis C, Hatch M, Lynfield Y, Duncanson C, Shalita A: Trivial or terrible? The psychological impact of psoriasis. Int J Dermatol 1995; 34: 101-105.
14. Delfino M, Holt EW, Taylor CR, Wittenberg E, Qureshi AA: Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriasis: a pilot study. J Am Acad Dermatol 2008; 59: 439-447.
15. Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti S, Lotti T, Schäfer G; EUROPSO Patient Survey Group: European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-736. (Pubitemid 44352553)
16. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T: The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-284.
17. Zachariae R, Zachariae H, Blomqvist K, Davidsson S, Molin L, Mork C, Sigurgeirsson B: Quality of life in 6,497 Nordic patients with psoriasis. Br J Dermatol 2002; 146: 1006-1016. (Pubitemid 34779481)
18. Finzi A, Mantovani L, Belisari A; Italian Association for Studies on Psoriasis: The cost of hospital-related care of patients with psoriasis in Italy based on the AISP study. J Eur Acad Dermatol Venereol 2001; 15: 320-324.
19. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T: Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139. (Pubitemid 38457271)
20. Huerta C, Rivero E, Rodriguez LA: Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007; 143: 1559-1565. (Pubitemid 350277774)
21. Gelfand JM, Troxel AB, Lewis JD, Kurd SK, Shin DB, Wang X, Margolis DJ, Strom BL: The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-1499. (Pubitemid 350277763)
22. Nast A, Kopp IB, Augustin M, et al: Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris. J Dtsch Dermatol Ges 2007; 5: 1-119.
23. Augustin M, Reich K, Reich C, Purwins S, Rustenbach SJ, Schäfer I, Radtke MA: Quality of psoriasis care in Germany - results of the national study PsoHealth 2007. J Dtsch Dermatol Ges 2008; 6: 640-645.
24. Schmid-Ott G, Künsebeck HW, Jäger B, Sittig U, Hofste N, Ott R, Malewski P, Lamprecht F: Significance of the stigmatization experience of psoriasis patients: a 1-year follow-up of the illness and its psychosocial consequences in men and women. Acta Derm Venereol 2005; 85: 27-32. (Pubitemid 40254676)
25. Schöffski O, Augustin M, Prinz J, Rauner K, Schubert E, Sohn S, Reich K: Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multicenter study. J Dtsch Dermatol Ges 2007; 5: 209-219. (Pubitemid 46361354)
26. Augustin M, Wenninger K, Gieler U, Schroth MJ, Chren M, Kupfer K, Gieler U: German adaption of the 'Skindex-29' questionnaire on quality of life in dermatology: validation and clinical results. Dermatology 2004; 209: 14-20.
27. Augustin M, Lange S, Wenninger K, Seidenglanz K, Amon U, Zschocke I: Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold system. Eur J Dermatol 2004; 14: 107-113. (Pubitemid 38510027)
28. Schaefer I, Rustenbach SJ, Zimmer L, Augustin M: Prevalence of skin disease in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169-172.
29. Lecluse LLA, Naldi L, Stern RS, Spuls PI: National registries of systemic treatment for psoriasis and the European 'Psonet' initiative. Dermatology DOI: 10.1159/000183757.
30. Augustin M, Schäfer I, Campbell K, Gothe H, Höer A, Klesse M, Osowski U, Radtke M, Glaeske G: Approaches on the description of health provision based on secondary data of the statutory health insurances - the example psoriasis. 2008. www.egms.de/en/meetings/dkvf2008/08dkvf169.shtml.
31. Reich K, Krüger K, Mössner R, Augustin M: Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1,511 patients with plaque-type psoriasis. Br J Dermatol, in press.
32. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K: Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter prospective cross-sectional study in Germany. Dermatology 2008; 216: 366-372. (Pubitemid 351630108)
33. Augustin M, Gajur AI, Reich C, Rustenbach SJ, Schaefer I: Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire. Dermatology 2008; 217: 101-106.
34. Gulliver W: Long-term prognosis in patients with psoriasis. Br J Dermatol 2008; 159(suppl 2):2-9.
35. Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY: The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008;159:997-1035.
36. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY: Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
37. Augustin M, Reich K, Radtke MA, Dierks C (eds): Quality of Life, Compliance and Empowerment in Psoriasis. Bremen, Uni-Med Science, 2007.
38. Finlay AY: Current severe psoriasis and the rule of tens. Br J Dermatol 2005; 152: 861-867.
39. Augustin M: PsoNet - more health care quality through regional psoriasis networks. J Dtsch Dermatol Ges 2008; 6: 263-264.
40. Boehncke WH, Adebajo A, Cauli A, Nash P, Salvarani C, Kavanaugh AF: Initiative for quality in psoriasis and psoriatic arthritis. J Rheumatol 2008; 35: 1431-1433. (Pubitemid 352000799)
41. Salek S, Roberts A, Finlay AY: The practical reality of using a patient-reported measure in a routine dermatology clinic. Dermatology 2007; 215: 315-319. (Pubitemid 47519260)